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Abstract 1 
Background 2 
The Crohn’s and Ulcerative Colitis (CUCU) questionnaire has previously been validated in 3 
patients with mild to moderate Crohn’s and ulcerative colitis (UC).  The aim of this study was 4 
to validate the tool in patients with acute severe UC. 5 
Methods 6 
We undertook a validation of the CUCQ in patients recruited to the CONSTRUCT trial.  We 7 
carried out psychometric analysis to examine the underlying dimensions of the scale, 8 
internal consistency and construct validity.  We carried out stepwise regression to examine 9 
which items accounted for the greatest variance in the scale.   10 
Results: We obtained complete data for 270 patients.  The internal consistency of the CUCQ 11 
was excellent (Cronbach’s alpha > 0.8).  The CUCQ scores achieved significant correlations 12 
with two generic quality of life scales (SF12 and EQ5D) demonstrating good construct 13 
validity.  Stepwise regression identified 16 items that accounted for greater than 95% of the 14 
variance of the CUCQ.  Only 3 of the 8 items selected for a short form in mild to moderate 15 
patients were selected for patients with acute severe UC. 16 
Conclusions: The CUCQ demonstrated good validity in our sample of acute severe UC 17 
patients.  Stepwise regression identified potential to shorten the tool, but that different 18 
items would be selected compared with less severe patients.  If the tool is to be applied 19 
across the spectrum of disease it would be more appropriate to use the full 32 items in the 20 
scale.  Further work to explore test-retest is required in acute patients. 21 
Word count 240 22 
 23 
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Introduction  1 
Ulcerative colitis (UC) is a chronic incurable relapsing inflammatory disorder which presents 2 
with a multitude of symptoms impairing patient quality of life1, 2. The symptoms associated 3 
with UC are unpredictable and there can be significant variation in symptoms both over time 4 
within the same patient, and with different patients. 5 
 6 
Measuring quality of life (QoL) in UC patients is important in order to assess changes in the 7 
patients’ condition over time and following treatment, and also to gain an insight into the 8 
patient perception of their condition and how this compares with clinical or objective 9 
outcomes. 10 
 11 
The aim of the COmparison of iNfliximab and ciclosporin in STeroid Resistant Ulcerative 12 
Colitis Trial (CONSTRUCT) was to compare the clinical and cost-effectiveness of ciclosporin 13 
and infliximab in treating steroid-resistant acute severe UC3, 4.  Recent findings from other 14 
investigators illustrated no difference between cicolpsorin and infliximab in their primary 15 
outcome of treatment failures, but they did not report Qol of patients following treatment5.   16 
As the National Institute for Health and Care Excellence (NICE) have described that the 17 
ultimate criteria for interventions in healthcare are effectiveness and cost effectiveness in 18 
improving the survival and quality of life of patients over extended periods, in undertaking 19 
the CONSTRUCT trial we chose a patient-reported outcome measure as the basis for our 20 
primary outcome measure. 21 
 22 
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Preliminary validation of the CUCQ in patients with mild to moderate disease confirmed that 1 
it met essential psychometric criteria 6.  This paper reports on the validation of the CUCQ 2 
within the context of the CONSTRUCT trial in patients with acute severe UC3, 4. 3 
 4 
Methods  5 
We used the standard psychometric approaches for validation of the CUCQ as outlined by 6 
Streiner and Norman7.  For this validation we undertook: principal components analysis to 7 
examine the underlying dimensions of the scale; calculation of Cronbach’s alpha to test the 8 
internal consistency of the scale; correlations with two generic quality of life scales (SF-12 9 
and EQ5D) to evaluate the construct validity of the scale; and stepwise regression to explore 10 
which items contributed most to the scale.  Details of the item generation process, piloting 11 
and initial validation of the CUCQ in a sample of mild to moderate patients have previously 12 
been reported6.    13 
 14 
Details of CUCQ scoring 15 
We calculated scores for the CUCQ thus: 16 
1. We scored questions with four responses as 0, 1, 2 or 3 in ascending severity.  17 
2. We scored questions with responses between 0 and 14 days as the actual value.  18 
3. We reversed the scoring of questions with wording in the reverse direction (Q7, Q22 and 19 
Q32) to code all questions in the same direction.  20 
4. We rescaled questions between 0 and 1 by dividing actual responses by their maximum 21 
score (3 or 14).  22 
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5. We calculated total CUCQ scores by summing all valid responses and dividing by the 1 
number of completed questions.  2 
6. The lower the CUCQ the better the respondent’s health.  3 
We calculated the CUCQ scores only when the patient had responded to at least 75% of the 4 
questions, i.e. 24/32.  If participants had completed fewer than 75% of the questions, we 5 
treated the total CUCQ score as missing.  We gave equal weight to each question of the 32 6 
questions. 7 
 8 
Validation of the CUCQ in the CONSTRUCT Randomised Controlled Trial  9 
We undertook validation of the CUCQ on the CONSTRUCT3, 4 trial sample.  We conducted 10 
psychometric analysis of the CUCQ in the following way:  11 
1. We examined the 32 sets of response frequencies for floor or ceiling effects.  12 
2. We calculated the Kaiser-Meyer-Olkin measure of adequacy (KMO) and Bartlett’s test to 13 
judge whether principal component analysis was appropriate.  14 
3. We calculated Cronbach’s alpha (which should exceed 0.7 for good internal consistency).  15 
4. We calculated item-total correlations for each question (which should exceed 0.2 for good 16 
homogeneity).  17 
5. We undertook principal components analysis to assess the underlying structure; we 18 
considered factors important if their eigenvalues were clearly greater than 1, and individual  19 
questions as useful if their factor loadings exceeded 0.4.  20 
6. We assessed the construct validity of the scale by examining the Pearson correlation  21 
between the CUCQ and two generic quality-of-life questionnaires – EQ-5D and SF-12.  22 
  23 
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Ethics 1 
We received ethical approval from the Research Ethics Committee for Wales (Ref 2 
08/MRE09/42); NHS Research & Development (R&D) approval from each participating Trust 3 
or Health Board; and Medicine and Healthcare Regulatory Agency (MHRA) approval to 4 
undertake the CONSTRUCT trial.  5 
 6 
Results 7 
Patient sample 8 
We had a total of 270 patients in our RCT validation sample.  Table 1 gives the demographic 9 
characteristics of the CONSTRUCT RCT sample. 10 
 11 
Validation of the CUCQ in the CONSTRUCT Randomised Controlled Trial   12 
We examined the data prior to undertaking principal components analysis.  The Kaiser-13 
Meyer-Olkin Measure of Sampling Adequacy (KMO) was 0.844; and the Barlett’s test of 14 
Sphericity was 0.000 indicating that the data were suitable principal components analysis. 15 
 16 
The internal consistency of the CUCQ in the RCT sample was excellent with a Cronbach’s 17 
alpha of 0.845.  Table 2 illustrates the item-total correlations and the maximum response 18 
rates for each of the 32 questions.  All but two of the questions (Q1 and Q9) had an item-19 
total correlation of less than 0.2.  In addition, only two of the questions had a response rate 20 
greater than 80% (Q1 and Q6).  Q1 was the only question that showed a slight ceiling effect, 21 
based on using the recommended value of 15% for the percentage of patients scoring the 22 
highest or lowest scores8. 23 
9 
 
 
The principal components analysis indicated that there were four main factors with an 1 
eigenvalue of greater than 1 (Table 3), and which explained approximately 42% of the 2 
variance in the data. Where questions loaded onto more than one factor, we attributed the 3 
question to the factor with the greater factor loading7.  The principal components analysis 4 
identified that the first factor covered emotional symptoms; the second bowel symptoms; 5 
the third social activities and the fourth general symptoms, with most questions exceeding 6 
the required factor loading of 0.4. 7 
 8 
Table 4 illustrates that the CUCQ scores from the CONSTRUCT RCT sample achieved 9 
significant correlations (p<0.001) with the two generic health-related quality of life scales 10 
(SF-12 Mental Component summary scores -0.588; Physical Component summary scores -11 
0.442 and the EQ-5D -0.459)) scores demonstrating good construct validity7. 12 
 13 
We carried out a stepwise regression to identify the potential to shorten the CUCQ and the 14 
smallest number of questions required to do so (Table 5).  Stepwise regression identified 16 15 
items that accounted for greater than 95% of the variance of the CUCQ.  The questions 16 
identified as being major contributors to a shortened scale in the CONSTRUCT RCT sample of 17 
acute patients were however different to those identified in mild to moderate patients, with 18 
only 3 of the 8 items selected for a short form in mild to moderate patients6 being selected 19 
for patients with acute severe UC. 20 
 21 
Discussion 22 
We previously validated the CUCQ in patients with stable or moderately active IBD6 where it 23 
demonstrated good psychometric properties.  It had not previously been applied to acute 24 
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severe patients however, so we needed to validate it on patients with severe disease.  We 1 
therefore tested the validity of the CUCQ within the CONSTRUCT trial3 on patients diagnosed 2 
with acute severe UC. 3 
 4 
Psychometric analysis of the CUCQ in the CONSTRUCT sample of acute severe patients 5 
demonstrated excellent internal consistency (Cronbach’s alpha > 0.8).  There were only a 6 
handful of questions which demonstrated item-total correlations less than 0.2, response 7 
rates of greater than 80% or ceiling effects.  Principal components analysis indicated that 8 
there were 4 main factors with an eigenvalue of greater than 1 and which explained 42% of 9 
the variance in the data.  The CUCQ scores also achieved significant correlations with the 10 
both the SF-12 mental and physical component summary scores and the EQ-5D 11 
demonstrating good construct validity.  Stepwise regression analysis identified that 16 12 
questions explained greater than 95% of the variance in the CUCQ when applied to the acute 13 
severe UC patients in the CONSTRUCT RCT sample.  Interestingly the questions that were 14 
identified as being the major contributors to a shorter scale were different in the acute 15 
sample to those identified in a mild to moderate sample6 (only 3 of the 8 questions 16 
identified for the CUCQ8 in the mild to moderate sample, were identified in the acute severe 17 
sample).  This would suggest that the full 32 questions in the CUCQ would be more 18 
appropriate to use across the spectrum of disease, to ensure that the changing picture of the 19 
disease on quality of life is captured.  20 
 21 
Although initial psychometric testing of the CUCQ demonstrated good validity, more work is 22 
needed to explore the responsiveness and test- retest validity of the CUCQ in an acute 23 
severe sample.  Although the CONSTRUCT RCT patients completed follow-up questionnaires, 24 
11 
 
 
there was insufficient data to satisfactorily undertake these analyses.  Further work is also 1 
needed to explore the usefulness of the individual factor scores in monitoring patient quality 2 
of life. 3 
 4 
There have been no questionnaires that have been suitable for patients who have 5 
undergone colectomy surgery.  We developed an extension to the CUCQ (CUCQ+), which 6 
included 10 additional questionnaires specifically for stoma patients, and which excluded 6 7 
non-relevant questionnaires from the CUCQ.  We undertook initial piloting and testing of the 8 
CUCQ+ within CONSTRUCT but need to gather additional data to undertake a full 9 
psychometric analysis (including principal components analysis, consistency, construct 10 
validity, responsiveness and test-rest validity).   11 
 12 
In order to be clinically applicable we aim to produce a questionnaire which could be applied 13 
across the spectrum of disease from mild to severe (including one that is applicable to 14 
patients who undergo colectomy surgery), to longitudinally to assess patient disease specific 15 
quality of life over time.  In order to be practical in clinical practice this questionnaire should 16 
be short, so we would aim to produce a questionnaire than captures the most important 17 
symptoms across the spectrum of disease severity.  Work is already being undertaken to 18 
recruit more patients to undertake this further validation work and development of a short 19 
combined severity form.   20 
  21 
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Table 1.  Clinical and demographic characteristics of the CONSTRUCT RCT participants  1 
 2 
Patient characteristic  RCT sample 
Maximum N=270 
Gender  
Male 170 
Female 100 
Mean age (years(SD)) at recruitment 40.06(15.31) 
Ethnicity 
White 
Asian or Asian British 
Black or Black British 
Other Ethnic Groups 
Mixed 
Missing 
 
250 
12 
3 
2 
0 
3 
Truelove & Witt Classification  
Severe 
Not Severe 
 
251 
16 
Mayo Score 
0 
1 
2 
3 
 
4 
4 
68 
183 
Co-morbidity  
Yes 
No 
 
44 
225 
Mean EQ5D (SD) 0.51 (0.30) 
Mean CUCQ (SD) 0.36 (0.13) 
Mean SF6D (SD) 0.56 (0.11) 
  3 
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Table 2.  The CUCQ questions, their item total correlations and their maximum response 1 
rate (CONSTRUCT RCT sample) 2 
Question Item-total 
correlation 
Maximum 
response 
rate 
1.On how many days over the last two weeks have you 
had loose or runny bowel movements? 
.131 88.1% 
2.On how many days in the last two weeks have you 
noticed blood in your stools? 
.230 70.4% 
3.On how many days over the last two weeks have you felt 
tired? 
.506 73.3% 
4.In the last two weeks have you felt frustrated? .493 41.5% 
5.In the last two weeks, has your bowel condition 
prevented you from carrying out your work or other 
normal activities? 
.481 41.9% 
6.On how many days over the last two weeks have you 
opened your bowels more than three times a day? 
.286 86.3% 
7.On how many days over the last two weeks have you felt 
full of energy? 
.318 74.4% 
8.In the last two weeks did your bowel condition prevent 
you from going out socially? 
.505 44.4% 
9.On how many days over the last two weeks have your 
bowels opened accidentally? 
.194 46.7% 
10.On how many days over the last two weeks have you 
felt generally unwell? 
.590 63.0% 
11.In the last two weeks have you felt the need to keep 
close to a toilet? 
.500 56.3% 
12.In the last two weeks, has your bowel condition 
affected your leisure or sports activities? 
.564 56.7% 
13.On how many days over the last two weeks have you 
felt pain in your abdomen? 
.396 57.8% 
14.On how many nights over the last two weeks have you 
been unable to sleep well (days if you are a shift worker)? 
.453 61.5% 
15.On how many nights in the last two weeks have you 
had to get up to use the toilet because of your bowel 
condition after you have gone to bed? 
.436 70.0% 
16.In the last two weeks have you felt depressed? .534 56.3% 
17.In the last two weeks have you had to avoid attending 
events where there was no toilet close at hand? 
.529 36.7% 
18 
 
 
18.On how many days over the last two weeks, have you 
had a problem with large amounts of wind? 
.270 40.0% 
19.On how many days over the last two weeks have you 
felt off your food? 
.294 27.0% 
20.Many patients with bowel problems have worries 
about their illness.  How often during the last two weeks 
have you felt worried? 
.508 34.8% 
21.On how many days over the last two weeks has your 
abdomen felt bloated? 
.396 31.5% 
22.In the last two weeks have you felt relaxed? .478 48.5% 
23.In the last two weeks have you been embarrassed by 
your bowel problem? 
.466 38.1% 
24.On how many days over the last two weeks have you 
wanted to go back to the toilet immediately after you 
thought you had emptied your bowels? 
.462 34.8% 
25.In the last two weeks have you felt upset? .568 60.0% 
26.On how many days over the last two weeks have you 
had to rush to the toilet? 
.409 61.9% 
27.In the last two weeks have you felt angry as a result of 
your bowel problem? 
.423 50.4% 
28.In the last two weeks, has your sex life been affected 
by your bowel problem? 
.391 45.2% 
29.On how many days over the last two weeks have you 
felt sick? 
.466 22.6% 
30.In the last two weeks have you felt irritable? .572 53.3% 
31.In the last two weeks have you felt lack of sympathy 
from others? 
.266 64.1% 
32.In the last two weeks have you felt happy? .377 54.8% 
 1 
  2 
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Table 3.  Principal component analysis of the CONSTRUCT CUCQ questions from the 1 
CONSTRUCT RCT sample based on a four factor solution.   2 
 Factors 
1 
Social 
2 
Psychol-
ogical 
3 
General 
4 
Bowel 
Percentage of factor’s contribution 22.13% 7.72% 6.64% 5.20% 
Eigenvalue 7.08 2.47 2.12 1.67 
Q5.In the last two weeks, has your bowel 
condition prevented you from carrying out your 
work or other normal activities? 
.709 
   
Q8.In the last two weeks did your bowel 
condition prevent you from going out socially? 
.872 
   
Q11.In the last two weeks have you felt the 
need to keep close to a toilet? 
.621 
   
Q12.In the last two weeks, has your bowel 
condition affected your leisure or sports 
activities? 
.803 
   
Q17.In the last two weeks have you had to 
avoid attending events where there was no 
toilet close at hand? 
.637 
   
Q28.In the last two weeks, has your sex life 
been affected by your bowel problem? 
.452 
   
Q4.In the last two weeks have you felt 
frustrated? 
 
-.714   
Q16.In the last two weeks have you felt 
depressed? 
 
-.696   
Q20.Many patients with bowel problems have 
worries about their illness.  How often during 
the last two weeks have you felt worried? 
 -.615   
Q22.In the last two weeks have you felt 
relaxed? 
 -.450   
Q23.In the last two weeks have you been 
embarrassed by your bowel problem? 
 -.592   
Q25.In the last two weeks have you felt upset?  -.725   
Q27.In the last two weeks have you felt angry 
as a result of your bowel problem? 
 -.754   
Q30.In the last two weeks have you felt 
irritable? 
 -.533   
Q31.In the last two weeks have you felt lack of 
sympathy from others? 
 -.364   
Q32.In the last two weeks have you felt happy?  -.368   
20 
 
 
Q1.On how many days over the last two weeks 
have you had loose or runny bowel 
movements? 
  .455  
Q2.On how many days in the last two weeks 
have you noticed blood in your stools? 
  .351  
Q3.On how many days over the last two weeks 
have you felt tired? 
  .514  
Q6.On how many days over the last two weeks 
have you opened your bowels more than three 
times a day? 
  .494  
Q7.On how many days over the last two weeks 
have you felt full of energy? 
  .483  
Q10.On how many days over the last two 
weeks have you felt generally unwell? 
  .485  
Q13.On how many days over the last two 
weeks have you felt pain in your abdomen? 
  .613  
Q14.On how many nights over the last two 
weeks have you been unable to sleep well (days 
if you are a shift worker)? 
  .411  
Q15.On how many nights in the last two weeks 
have you had to get up to use the toilet 
because of your bowel condition after you have 
gone to bed? 
  .445  
Q19.On how many days over the last two 
weeks have you felt off your food? 
  .509  
Q29.On how many days over the last two 
weeks have you felt sick? 
  .355  
Q9.On how many days over the last two weeks 
have your bowels opened accidentally? 
   .316 
Q18.On how many days over the last two 
weeks, have you had a problem with large 
amounts of wind? 
   .684 
Q21.On how many days over the last two 
weeks has your abdomen felt bloated? 
   .586 
Q24.On how many days over the last two 
weeks have you wanted to go back to the toilet 
immediately after you thought you had 
emptied your bowels? 
   .547 
Q26.On how many days over the last two 
weeks have you had to rush to the toilet? 
   .534 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
a. Rotation converged in 15 iterations. 
 1 
  2 
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Table 4.  Correlations between the CUCQ and the SF-12 MCS and PCS and EQ-5D in the 1 
CONSTRUCT RCT sample 2 
Scale CUCU  
SF-12 MCS -0.588* 
SF-12 PCS  -0.452* 
EQ5D  -0.459* 
*p<0.001 Pearson’s correlation 3 
  4 
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Table 5.  Model summary of the CUCQ questions in the CONSTRUCT RCT sample 1 
Questions Cumulative 
% of variance 
Q10. On how many days over the last two weeks have you felt generally 
unwell? 34.5 
Q30. In the last two weeks have you felt irritable? 
58.8 
Q12. In the last two weeks, has your bowel condition affected your leisure or 
sports activities? 67.4 
Q3. On how many days over the last two weeks have you felt tired? 
74.0 
Q23. In the last two weeks have you been embarrassed by your bowel 
problem? 79.1 
Q24. On how many days over the last two weeks have you wanted to go back 
to the toilet immediately after you thought you had emptied your bowels? 81.8 
Q16. In the last two weeks have you felt depressed? 
84.0 
Q29. On how many days over the last two weeks have you felt sick? 
86.2 
Q5. In the last two weeks, has your bowel condition prevented you from 
carrying out your work or other normal activities? 87.8 
Q18. On how many days over the last two weeks, have you had a problem 
with large amounts of wind? 89.5 
Q32. In the last two weeks have you felt happy? 
90.8 
Q28. In the last two weeks, has your sex life been affected by your bowel 
problem? 91.7 
Q14. On how many nights over the last two weeks have you been unable to 
sleep well (days if you are a shift worker)? 92.7 
Q20. Many patients with bowel problems have worries about their illness.  
How often during the last two weeks have you felt worried? 93.7 
Q17. In the last two weeks have you had to avoid attending events where 
there was no toilet close at hand? 94.5 
Q2. On how many days in the last two weeks have you noticed blood in your 
stools? 95.2 
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Q26. On how many days over the last two weeks have you had to rush to the 
toilet? 95.8 
Q31. In the last two weeks have you felt lack of sympathy from others? 
96.3 
Q21. On how many days over the last two weeks has your abdomen felt 
bloated? 96.7 
Q27. In the last two weeks have you felt angry as a result of your bowel 
problem? 97.1 
Q22. In the last two weeks have you felt relaxed? 
97.5 
Q19. On how many days over the last two weeks have you felt off your food? 
97.8 
Q13. On how many days over the last two weeks have you felt pain in your 
abdomen? 98.1 
Q11. In the last two weeks have you felt the need to keep close to a toilet? 
98.4 
Q9. On how many days over the last two weeks have your bowels opened 
accidentally? 98.7 
Q4. In the last two weeks have you felt frustrated? 
98.9 
Q15. On how many nights in the last two weeks have you had to get up to 
use the toilet because of your bowel condition after you have gone to bed? 99.2 
Q7. On how many days over the last two weeks have you felt full of energy? 
99.4 
Q8. In the last two weeks did your bowel condition prevent you from going 
out socially? 99.6 
Q25. In the last two weeks have you felt upset? 
99.7 
Q1. On how many days over the last two weeks have you had loose or runny 
bowel movements? 99.9 
Q6. On how many days over the last two weeks have you opened your 
bowels more than three times a day? 100 
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